Akèy › Kansè Poumon ki pa ti selil › Rhode Island › Providence
Etid klinik pou Kansè Poumon ki pa ti selil nan Providence, RI
12 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Providence (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Rhode Island Hospital, Providence
- Roger Williams Medical Center, Providence
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 1/2
- Research Site, Providence
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Ap rekriteFaz 1/2
- Rhode Island Hospital, East Providence · 2 mi lwen
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Lifespan Cancer Institute, Providence
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
Ap rekriteFaz 2
- Rhode Island Hospital, Providence
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Ap rekriteFaz 3
- Rhode Island Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- Women and Infants Hospital of Rhode Island, Providence
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Ap rekriteFaz 1
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Ap rekriteFaz 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Providence
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Ap rekriteFaz 2
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Ap rekriteEtid obsèvasyon
- Rhode Island Hospital, Brown University, Providence
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Providence
- Kansè ovè15 etid
- Kansè Endomèt14 etid
- Obèsite14 etid
- Kansè (tout kalite)12 etid
- Maladi Crohn12 etid
- Kolit Ulseratif11 etid
- Kansè nan tete11 etid
- Leksemi mieloïd egi10 etid
- Kansè Metastatik9 etid
- Sipwa9 etid
- Maladi Alzheimer8 etid
- Twoub Konsomasyon Alkòl (AUD)8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.